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Abstract  Systemic  lupus  erythematosus  (SLE)  is  a  multiorgan  autoimmune  disease  of  unknown
etiology with  many  clinical  manifestations.
We  report  the  ﬁrst  case  of  SLE  in  which  visual  alterations  were  evaluated  with  multichannel
perimetry.
Some achromatic  and  color  vision  alterations  may  be  present  in  SLE,  especially  when  treated
with hydroxychloroquine.  The  sensitivity  losses  detected  in  the  chromatic  channels  in  the  cen-
tral zone  of  the  visual  ﬁeld  were  consistent  with  the  results  of  the  FM  100  Hue  color  test.
Likewise, the  multichannel  perimetry  detected  sensitivity  losses  in  the  parafoveal  area  for
both chromatic  channels,  especially  for  the  blue-yellow.
© 2016  Spanish  General  Council  of  Optometry.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Resumen  El  lupus  eritematoso  sistémico  (LES)  es  una  enfermedad  autoinmune  multiorgánica
Vías  visuales; de etiología  desconocida,  con  muchas  manifestaciones  clínicas.
Sensibilidad  al
contraste;
Maculopatía  por
hidroxicloroquina
Reportamos  el  primer  caso  de  LES  en  el  que  se  evaluaron  las  alteraciones  visuales  utilizando
la perimetría  multicanal.
En  el  LES  pueden  presentarse  ciertas  alteraciones  acromáticas  y  de  la  visión  del  color,  espe-
cialmente  cuando  se  trata  la  enfermedad  con  hidroxicloroquina.  Las  pérdidas  de  sensibilidad
detectadas  en  los  canales  cromáticos  de  la  zona  central  del  campo  visual  fueron  consistentes∗ Corresponding author at: Department of Optics, Pharmacology and Anatomy, University of Alicante, Crta San Vicente del Raspeig s/n,
San Vicente del Raspeig, 03016 Alicante, Spain.
E-mail address: dolores.fez@ua.es (D. de Fez).
http://dx.doi.org/10.1016/j.optom.2016.04.001
1888-4296/© 2016 Spanish General Council of Optometry. Published by Elsevier Espan˜a, S.L.U. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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con  los  resultados  de  la  prueba  de  color  FM  100  Hue.  De  igual  modo,  la  perimetría  multicanal
detectó  pérdidas  de  sensibilidad  en  el  área  parafoveal  para  ambos  canales  cromáticos,  y  en
especial para  el  azul-amarillo.
©  2016  Spanish  General  Council  of  Optometry.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este  es  un
art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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FSystemic  lupus  erythematosus  (SLE)  is  a  multiorgan
utoimmune  disease  of  unknown  etiology  with  many  clini-
al  manifestations.  The  eye  can  be  affected  by  the  disease,
ith  risk  of  retinal  hemorrhage  and  sudden  loss  of  vision
5%).1 Ocular  signs  and  symptoms  include  cotton  wool  spots
soft  exudates),  microaneurysms  and  vascular  tortuosity  in
he  retina,  photophobia,  dry  eye  syndrome,  pain,  red  eye
nd  even  complete  loss  of  vision.1 The  pharmacological
reatment  of  SLE  can  alter  signiﬁcantly  the  visual  ﬁeld  and
olor  vision.2 Several  authors  have  reported  a  slight  increase
f  the  color  threshold  (specially  for  yellow),3 retinopa-
hy  induced  by  hydroxychloroquine  intake  generating  slight
hanges  in  color  vision  and  the  presence  of  a  paracentral
cotoma,4 and  retinopathy  induced  by  chloroquine  intake.5
ultichannel  perimetry6--8 is  a  relatively  new  clinical  tool
hat  allows  the  clinician  to  measure  the  contrast  sensitiv-
ty  for  the  magno,  parvo,  and  koniocellular  pathways,  with
he  possibility  of  detecting  incipient  alterations  in  each  of
hese  visual  pathways  that  could  be  not  detected  in  a  con-
entional  perimetric  exam.  We  report  the  ﬁrst  case  of  SLE  in
hich  visual  alterations  were  evaluated  with  multichannel
erimetry.
ase report
e  report  the  case  of  a  visually  asymptomatic  46-year
ld  woman  diagnosed  with  SLE  and  under  treatment
ith  hydroxychloquine  during  15  years  (hydroxychloroquine
00  mg/day).  The  right  eye  (RE)  had  a  manifest  refraction
f  −1.00  D  and  corrected  distance  visual  acuity  (CDVA)  of
0/20.  The  left  eye  (LE)  had  a  manifest  refraction  of  (+4.00)
−1.75)  20◦ and  CDVA  of  20/25.  Intraocular  pressure  was
2.7  and  13.3  mm  Hg  in  RE  and  LE,  respectively.  Alterations
ere  not  detected  either  in  the  fundoscopic  examination,
0-2  automated  perimetry  or  in  the  examination  of  the
acular  structure  by  optical  coherence  tomography  (Soct
opernicus  HR,  Optopol).  The  results  of  the  color  vision
xamination  (FM  100  Hue  test)  showed  total  and  partial  error
core  out  of  the  range  of  normality  for  both  eyes  (RE:  TES-
28,  RG-34,  BY-94;  LE:  TES-144,  RG-72,  BY-72).  The  error
alue  in  the  red-green  (RG)  axis  was  worse  in  LE,  whereas
he  error  value  in  the  blue-yellow  (BY)  axis  was  worse  in
E.  Regarding  the  evaluation  of  the  achromatic  contrast
ensitivity,  a  decrease  in  the  contrast  sensitivity  function
CSF)  was  observed  in  both  eyes  for  high  spatial  frequen-
ies  that  was  more  signiﬁcant  in  LE  (Fig.  1).  Besides  these
ests,  visual  perimetry  was  performed  with  a  multichannel
erimeter,6--8 selecting  the  following  channels  and  frequen-
ies  to  be  examined9,10:
h
m
t
migure  1  Achromatic  contrast  sensitivity  function  (CSF)
btained  by  means  of  the  CSV-1000E  test  for  both  eyes.
 Achromatic  channel  of  magnocellular  origin  (A):  spatio-
temporal  sinusoidal  patterns  of  0.5  cycles/degree
ﬂickering  at  25  Hz.
 Parvocellular  red-green  channel  (RG):  0.5  cycles/degree
and  0  Hz.
 Koniocellular  blue-yellow  channel  (BY):  0.5  cycles/degree
and  0  Hz.
The  results  of  this  test  for  RE  and  LE  are  displayed  in
ig.  2.
All  these  visual  alterations  suggest  a  very  incipient
ydroxychloroquine  maculopathy,  with  no  OCT  or  10-2  auto-
ated  perimetry  alterations.  This  information  was  sent  to
he  rheumatologist  who  decided  to  discontinue  the  treat-
ent.
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Figure  2  Results  obtained  with  the  multichannel  perimetry.  Top:  maps  of  sensitivity  (left),  total  deviation  (center)  and  pattern
deviation (right)  for  each  eye  and  mechanism:  achromatic  (A),  red-green  (RG)  and  blue-yellow  (BY).  Bottom:  statistical  values  for
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ceach mechanism:  the  medium  defect  (MD)  and  pattern  standa
(p-value) of  the  comparison  with  the  normal  healthy  pattern.
Discussion
Multichannel  perimetry  measures  the  detection  thresholds
in  a  horizontal  ﬁeld  of  60◦ ×  40◦,  centered  at  the  fovea,  and
at  a  viewing  distance  of  25  cm.  It  allows  the  clinician  to
detect  incipient  alterations  in  magno-,  parvo-,  and  konio-
cellular  pathways  that  cannot  be  detected  in  a  conventional
perimetric  exam.  To  this  date,  this  technology  has  been
reported  to  detect  impairment  in  the  achromatic  and  RG
and  BY  chromatic  mechanisms  in  a  case  of  essential  tremor
and  in  Alzheimer.11,12
The  alterations  detected  in  the  achromatic  channel
with  multichannel  perimetry  were  not  consistent  with
the  CSF  outcomes,  as  expected.  The  stimuli  during  the
measurement  of  the  CSF  facilitate  the  response  of  the
achromatic  parvocellular  channel,  whereas  the  high  tem-
poral  frequency  in  the  multichannel  perimetry  estimulates
the  response  of  the  magnocellular  channel.  Our  results
conﬁrm  the  different  behavior  of  these  mechanisms  in  the
patient  evaluated.  In  our  case,  the  multichannel  perimetry
detected  signiﬁcant  losses  of  sensitivity  in  RE  whereas
the  CSF  showed  data  values  with  more  departures  from
normality  in  LE.  Furthermore,  losses  were  not  only  detected
in  fovea,  but  also  in  the  inferior  portion  of  the  visual  ﬁeld.
These  parafoveal  losses  may  be  the  consequence  of  the
c
w
p
dviation  (PSD)  are  shown  as  well  as  the  statistical  signiﬁcance
dverse  effect  of  the  pharmacological  treatment.  The
ntake  of  hydroxychloroquine  for  SLE  has  been  associated
ith  a  reduced  parafoveal  retinal  sensitivity13 potentially
ue  to  an  early  damage  of  the  ganglion  cells  and  their
hotoreceptors  of  this  region.5,14 This  evidence  is  the
rst  showing  the  presence  of  these  visual  alterations  in  a
otential  case  of  hydroxychloroquine  maculopathy  in  SLE.
Concerning  the  color  vision,  we  can  observe  in  Fig.  2
hat  there  was  a  signiﬁcant  decrease  in  retinal  sensitivity
ompared  to  the  normal  pattern  for  red-green  (RG)  and
lue-yellow  (BY)  channels  in  both  eyes.  The  PSD  values
onﬁrm  that  localized  losses  detected  were  statistically  sig-
iﬁcant  for  the  RG  channel  in  both  eyes.  The  sensitivity
osses  detected  in  the  chromatic  channels  in  the  central
one  of  the  visual  ﬁeld  were  consistent  with  the  results
f  the  FM  100  Hue  color  test.  Likewise,  the  multichannel
erimetry  detected  sensitivity  losses  in  the  parafoveal  area
or  both  chromatic  channels,  especially  for  the  BY.  Future
tudies  should  conﬁrm  if  these  parafoveal  alterations  are
onsistent  with  the  defects  detected  by  microperimetry  in
ases  of  hydroxychloroquine  toxicity  and  if  the  chromatic
hanges  are  more  incipient  than  microperimetric  signs.  Like-
ise,  future  studies  should  conﬁrm  if  these  multichannel
erimetric  alterations  are  also  related  to  changes  in  fun-
us  autoﬂuorescence  and  multifocal  electroretinogram  that
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ave  been  also  shown  to  be  useful  in  the  detection  of  hydrox-
chloroquine  maculopathy.15
In  conclusion,  some  achromatic  and  color  vision
lterations  may  be  present  in  incipient  stages  of  hydrox-
chloroquine  maculopathy  in  SLE.  Future  studies  should
nvestigate  if  these  color  vision  alterations  detected  by
eans  of  multichannel  perimetry  may  be  used  for  the
etection  of  incipient  stages  of  SLE  or  incipient  hydroxy-
hloroquine  toxicity  when  treated  cases  are  analyzed.
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